📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Metyrapone in treatment-resistant depression. (2012)

First Author: Sigalas PD

Attributed to: Antiglucocorticoid augmentation of antiDepressants in Depression (The ADD study) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/2045125312436597

PubMed Identifier: 23983967

Publication URI: http://europepmc.org/abstract/MED/23983967

Type: Journal Article/Review

Volume: 2

Parent Publication: Therapeutic advances in psychopharmacology

Issue: 4

ISSN: 2045-1253